About Jeff Heier, MD

Jeffrey S. Heier, M.D., is the Co-President and Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston (OCB), one of the largest and most prestigious multi-specialty ophthalmology practices in the United States.

Dr. Heier received his medical degree from Boston University, then did a transitional internship and ophthalmology residency at Fitzsimons Army Medical Center. Between his internship and residency, Dr. Heier served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star. Dr. Heier then completed a vitreoretinal fellowship at Ophthalmic Consultants of Boston/Tufts University School of Medicine.

Dr. Heier is on the Executive Board of the Retina Society, the Executive Committee of the American Society of Retina Specialists, is the Past President of the New England Ophthalmological Society, and a member of the Macula Society. Dr. Heier is the past Secretary of Online Education for the American Academy of Ophthalmology and the past President of the Center for Eye Research and Education Foundation in Boston, MA.

Dr. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. He serves on the Scientific Advisory Board or as Clinical Design Consultant to over thirty biotechnical or pharmaceutical companies. Dr. Heier is the lead investigator on numerous clinical trials, ranging from phase I safety and proof of concept trials to phase IV post-marketing studies.

Dr. Heier lectures nationally and internationally on retinal research and the innovative approach to the treatment of retinal diseases. He has authored or co-authored more than 100 works in peer-reviewed journals, as well as served as a reviewer for the New England Journal of Medicine, Lancet, Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, Retina, and numerous other journals.

Dr. Heier enjoys spending time with his wife of over 30 years and his two beautiful daughters, one a staff member at the American Ballet Theatre in NYC and the other a dancer in the Pennsylvania Ballet.

Departments, Centers, & Programs:

Clinical Interests:



North Shore Physicians Group
81 Highland Ave
Salem, MA 01970
Phone: 978-741-1200

Medical Education

  • MD, Boston University
  • Residency, Fitzsimons Army Medical Center
  • Fellowship, Tufts/OCB

American Board Certifications

  • Ophthalmology, American Board of Ophthalmology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.



  • Heier JS, Wykoff CC, Waheed NK, et al. Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor Beta for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial. Ophthalmol. Accepted for publication.

    Heier JS, Ho AC, Samuel MA, et al. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study. Ophthalmol Retina. Manuscript accepted for publication; available online 2019 November 19.

    Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, et al. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. Ophthalmology. 2019 Jul 16.

    Ehlers JP, Uchida A, Hu M, Figueiredo N, Kaiser PK, Heier JS, et al. Higher-Order Assessment of OCT in Diabetic Macular Edema form the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index. Ophthalmol Retina. 2019 Jul 6.

    Or C, Heier JS, Boyer D, Brown D, Shah S, Alibhai AY, et al. Vascularized Drusen: a Cross-Sectional Study. Int J Retina Vitreous. 2019 Aug 20;5:36.

    Feltgen N, Ogura Y, Boscia F, Holz FG, Korobelnik JF, Brown DM, Heier JS, et al. Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies. Ophthalmol Retina. 2019 Jul;3(7):553-560.


Reviews: Comments and Ratings